Fulcrum Therapeutics Inc
NASDAQ:FULC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fulcrum Therapeutics Inc
NASDAQ:FULC
|
US |
|
DCM Corp
KRX:024090
|
KR |
|
mCloud Technologies Corp
XTSX:MCLD
|
CA |
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
US |
|
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
BR |
|
C
|
Cheetah Net Supply Chain Service Inc
NASDAQ:CTNT
|
US |
|
E
|
Equites Property Fund Ltd
JSE:EQU
|
ZA |
|
scPharmaceuticals Inc
NASDAQ:SCPH
|
US |
|
Stevia Corp
OTC:STEV
|
US |
|
S
|
Strauss Group Ltd
TASE:STRS
|
IL |
|
Insight Enterprises Inc
NASDAQ:NSIT
|
US |
Shareholder Yield
Current shareholder yield for FULC is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
FULC Price
Fulcrum Therapeutics Inc
| Average Annual Return | -9.08% |
| Standard Deviation of Annual Returns | 51.68% |
| Max Drawdown | -93% |
| Market Capitalization | 448.1m USD |
| Shares Outstanding | 66 600 000 |
| Percentage of Shares Shorted | 8.43% |
